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Summary 
Type 1 intetferons a and fI are found to be potent inhibi- 
tors of IL-7-induced growth of early B lineage cells, 
while having no effect on cell growth induced by IL-2, 
IL-3, IL-4, or autogenous factors. The combination of 
IL-7 and interferons a/p induces bcl-2 down-regulation 
and cell death by apoptosis. These conclusions were 
derived initially from experiments employing exoge- 
nous cytokines, but functional type 1 interferons are 
also shown to be produced by resident bone marrow 
macrophages. As physiological modulators of IL-7- 
driven proliferation and cell survival, interferons a/p 
may cooperate with other homeostatic factors to main- 
tain the balanced production of normal B lineage cells. 
Introduction 
B cell development proceeds in an orderly fashion charac- 
terized by sequential immunoglobulin gene rearrange- 
ment and the differential expression of cell surface mark- 
ers (Tonegawa, 1983; Alt et al., 1992; Hardy et al., 1991). 
Committed progenitor B (pro-B) cells rearrange their VDJ 
gene segments to differentiate into precursor B (pre-B) 
cells that express tr heavy chain in the cytoplasm or on 
the cell surface in association with surrogate light chains 
encoded by h5 and VpreB genes (Cooper and Burrows, 
1990; Lassoued et al., 1993; Karasuyama et al., 1994; 
Desiderio, 1994). Following productive VJ light chain gene 
rearrangement in either the K or the I locus, pre-B CellS 
give rise to surface immunoglobulin M+ (IgM+) B cells with 
the potential for plasma cell differentiation (Hendershot et 
al., 1987; Reth, 1992). 
The growth and differentiation of pro- and pre-B cells 
can be positively influenced by a number of cytokines, 
including interleukin-7 (IL-7) stem cell factor (SCF, c-kit 
ligand), insulin-like growth factor 1 (IGF-l), pre-B cell 
growth-stimulating factor (PBSF), pre-B cell colony- 
enhancing factor (PBEF), pre-B costimulatory factor (BST- 
l), and others (Kincade, 1994; Namen et al., 1988; Rolink 
et al., 1991a; Billipset al., 1992; Gibson et al., 1993; Naga- 
sawa et al., 1994; Samal et al., 1994; Kaisho et al., 1994). 
IL-7 is also a potent growth factor for immature and mature 
T cells (Morrisseyet al., 1989; Grabstein et al., 1990; Armi- 
tage et al., 1990; Conlon et al., 1989). Band T lymphocyte 
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development is severely impaired in mice treated with neu- 
tralizing antibodies either against IL-7 or its receptor (IL- 
7R) (Grabstein et al., 1993; Sudo et al., 1993) or by tar- 
geted disruption of the IL-7R through homologous 
recombination (Peschon et al., 1994). Although IL-7 is re- 
quired, it is insufficient for lymphocyte development. SCF, 
IGF-1, and PBSF can act synergistically with IL-7 to en- 
hance the proliferation of pro-B cells (reviewed by Kincade, 
1994). PBEF can enhance pre-B cell colony formation in- 
duced by IL-7, and SCF and BST-1 may augment stromal- 
dependent pre-B cell growth. Expression of most of these 
growth factors is not restricted to lymphoid tissues and, 
with the exception of IL-7, none of these factors has signifi- 
cant activity when used alone. The proliferation of early 
B lineage cells at distinct developmental stages may thus 
be regulated by combinations of microenvironmental fac- 
tors interacting with their complementary receptors on pro- 
and pre-B cells. 
Factors that can inhibit B lymphocyte development in- 
clude IL-4, IL-l, transforming growth factor 8 (TGFP), inter- 
feron-y (IFNy), estrogen, and IL-3 (Kincade et al., 1994; 
Rennick et al., 1987; Dorshkind, 1988; Billips et al., 1990; 
Lee et al., 1989; Hayashi et al., 1989; Grawunder et al., 
1993; Garvy and Riley, 1994; Gimble et al., 1993; Medina 
et al., 1993; Medina and Kincade, 1994; Hirayama et al., 
1994). IL-4 inhibits the stromal cell-dependent growth of 
bone marrow-derived pre-B cells (Rennick et al., 1987). In 
long-term cultures of bone marrow, IL-1 stimulates stromal 
cells to secrete colony-stimulating factors, which contrib- 
ute to myelopoiesis at the expense of B lymphopoiesis 
(Dorshkind, 1988). IL-l and IL-4 can also inhibit the differ- 
entiation of pro-B cells into cytoplasmic fr+ pre-B cells in- 
duced by stromal cell-derived factors (Billips et al., 1990). 
TGF6, a growth inhibitor for mature B cells, can also inhibit 
the proliferation of an IL-7-responsive subpopulation of 
8220’ cells (Lee et al., 1989; Hayashi et al., 1989). IFNy 
can serve as a growth inhibitor for early B lineage cells 
that require IL-7 or both IL-7 and stromal cells for their 
growth (Grawunder et al., 1993; Garvy and Riley, 1994) 
although not all IL-7-dependent cells are sensitive to IFNy 
(Gimble et al., 1993). Sex hormones, such as estrogen, 
may also dramatically inhibit early B cell development (Me- 
dina et al., 1993; Medina and Kincade, 1994). While these 
factors may inhibit B lymphopoiesis directly or indirectly, 
the mechanism by which they counteract the influence of 
positive growth factors is still unclear. 
During the course of examining the transcriptional reg- 
ulation of the pre-B cell-specific gene, BP-llglutamyl 
aminopeptidase (Cooper et al., 1986; Wu et al., 1990), we 
identified an IFN-responsive element (IRE) in the promoter 
region. IRE can bind two transcription factors, IFN regula- 
tory factors 1 and 2 (IRF-1 and IRF-2) induced by the type 
1 IFNs. While BP-l gene expression was observed to be 
up-regulated by IFNa and lFN8 in a number of pre-B cell 
lines, we noticed that growth of the IL-7-dependent cell 
lines was inhibited. This prompted an analysis that reveals 
that the proliferation of early B lineage cells induced by 
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IL-7 is selectively antagonized by IFNal5. Moreover, the 
type 1 IFNs are constitutively produced by resident bone 
marrow cells and thus could serve as physiological regula- 
tors of early B cell development. 
Results 
Differential Effects of IFNdp on the Growth of B 
Lineage Cell Lines 
We initially tested the effects of IFNa/8 on the growth of 
six transformed cell lines representing different stages in B 
cell development and two IL-7dependent pre-B cell lines, 
Scidl and DW34. While the growth of the Scid7 and DW34 
cells was strongly inhibited by IFNa/6, the growth of the 
WEHl231, WEH1279, and Ag8 tumor cell lines was not 
significantly affected (Figure 1A) and only a modest inhibi- 
tory effect was observed for the 3889, Erb#6, and 702/3 
cell lines at relatively high doses of IFNaI8. This treatment 
did not affect cell viability of the transformed cell lines, but 
the viability of the Scid7 and DW34 cells was significantly 
reduced by IFNa/f3 treatment (Table 1). 
To test further the possibility that IFNa/6 selectively in- 
hibits the cell growth induced by IL-7, we examined the 
d 
h 
Figure 1. IFNa and 3 Effects on the Growth of 
Lymphoid Cell Lines 
(A) The effect of IFNa and 6 on proliferation 
of B lineage cell lines. Cells (200 ul at l-2 x 
10Vml) were cultured for 3 days in 96well 
flat-bottomed plates with various concentra- 
tions of IFNaQ3. For the IL-7-dependent cell 
lines Scid7 and DW34. 100 U/ml (open 
squares) or 10 U/ml (open circles) of IL-7 was 
used, and a control culture without IL-7(-IL-7) 
was included. DNA synthesis was measured 
by PH]thyrnidine uptake as described in Experi- 
mental Procedures, except for the 3669 cells 
which were cultured at 10Vml in 24well flat- 
bottomed culture plates, and the cells were 
counted 3 days later. 
(B) The effect of IFNa and p on proliferation of 
cell lines that are dependent on different cyto- 
kines (IL-2, IL-3, IL-4, and IL-7). Cells (l-2 x 
10Vml) were cultured for 3 days with 100 U/ml 
(open squares) or 10 U/ml (open circles) of the 
essential cytokine in the presence of lFNul3 at 
different concentrations. For each cell line, a 
control culture without cytokine is included. 
effect of lFNal8 on cell lines that are dependent on the IL-2 
(HT2AB and CTLL-2), IL-3 (FDC-1) or IL-4 (CT4S) growth 
factors, as well as four additional IL-7-dependent cell lines 
(DIF9, 5.7.10., lXNIPB, and 2E8). While the growth of all 
four IL-7-dependent cell lines was sharply curtailed by 
lFNa@ treatment (Figure 1 B, e-h), none of the four IL-7- 
independent cell lines was affected; this was true at either 
Table 1. IFNo/ Treatment Induces Apoptosis in IL-7-Dependent 
Cell Lines 
Cell Treatment 
Cell line (Phenotype) IL-7 None IL-7 + IFNa/P 
Scid7 (Pro-B) 2’ 24 36 
DIF9 (Pro-B) 3 69 61 
DW34 (Pre-B) 5 29 34 
1XNIPB (Pre-B) 3 30 15 
57.10 (Pre-B) 3 94 42 
2E8 (Pre-B/B) 5 96 47 
’ Percent of cells with < 2n DNA. The cells were cultured for 3 days 
with IL-7 (100 U/ml), IL-7 plus lFNal6 (1,000 U/ml), or without either. 
These results were confirmed in a repeat experiment of the same 
design. 
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high or low doses of IL-2, IL-3, or IL-4 (Figure 18, a-d). 
Correspondingly, lFNal8 had no effect on cell viability in 
IL-7-independent lines, whereas lFNal8 induced cell 
death in all six IL-7-dependent cell lines. Cell viability also 
declined sharply following factor deprivation (Table l), 
consistent with the fact that these cells are dependent on 
specific cytokines for their growth and survival. In these 
experiments, the dramatic effect of lFNal8 on the IL-7- 
dependent cells was observed in the absence of stromal 
cells or other types of feeder cells. 
Additional evidence that IL-7-derived growth signals are 
selectively sensitive to lFNal8 was obtained in experi- 
ments employing a pre-B cell line transformed by the erb 
virus. Growth of the Erb#6 cell line is IL-7 independent 
but proliferation can be enhanced 2-to 4-fold by IL-7 treat- 
ment, indicating that IL-7 provides an additional growth 
signal to that inherent to Erb virus transformation. While 
IFNalb treatment had minimal effect on growth of the 
Erb#6 cells in the absence of IL-7, the IL-7 enhancement of 
proliferation was abolished by lFNal8 in a dose-dependent 
manner, leaving the baseline growth rate unchanged (Fig- 
ure 1 A, b). 
IFNa and IFNp Induce Apoptosis In IL-7-Dependent 
Cell Lines 
Having observed that the inhibition of IL-7-dependent cell 
growth by type 1 IFNs is accompanied by a decline in cell 
viability, we examined whether this involved cell death 
by apoptosis. For this purpose, cell cycle analysis was 
performed by determining DNA content. In each of the six 
IL-7-dependent cell lines, IFNa/8 plus IL-7 or IL-7 depriva- 
tion for 3 days induced the appearance of cells that con- 
tained subdiploid (<2n) amounts of DNA (Table l), the 
percentage of which paralleled the observed decline in cell 
viability. In contrast, the IL-3-dependent cell line, FDC-1, 
showed no signs of apoptosis in the presence of IFNal 
f3, although approximately 70% of the FDC-1 cells were 
induced to undergo apoptosis following IL-3 removal. 
IFNal8 treatment also did not induce apoptosis of the 
transformed IL-7-independent Erb#6 or 3889 cell lines 
(data not shown). 
The induction of cell death by apoptosis was confirmed 
by the appearance of fragmented DNA (Figure 2). DNA 
ladders were found in both Scid7 and FDC-1 cells after 
specific growth factor (IL-7 or IL-3) deprivation. In addition, 
lFNal8 induced DNA fragmentation in the IL-7-dependent 
Scid7, but not in the IL-3-dependent FDC-1 cells, in keep- 
ing with the analysis of DNA content. Although bcl-2 was 
expressed in both cell lines, the levels of bcl-2 in IFNal 
S-treated Scid7 cells were reduced (37%-460/o at l-3 
days), while in IFNa/P-treated FDC-1 cells the bcl-2 levels 
were maintained; bcl-2 levels were reduced by factor with- 
drawal from both Scid7 (23% reduction) and FDC-1 (43% 
reduction) cell lines. When the effect of IFNalf3 on cell 
growth and viability was examined for an IL-7-dependent 
cell line derived from an Etrbcl-2 transgenic mouse, cellu- 
lar proliferation was substantially inhibited by IFNa/P, 
whereas cell viability was minimally affected (Figure 3). 
The data suggest that bcl-2 down-regulation expression 
is not required for the growth inhibition, but is important 
Scid7 FDC-1 
Figure 2. Effects of lFNal8 and Cytokine Deprivation on DNA Frag- 
mentation in the Scid7 (IL-7-Dependent) and FDC-1 (IL-3-Dependent) 
Ceil Lines 
Cells were cultured as in Figure 1 and DNA was extracted before 
analysis by electrophoresis in an agarose gel as described in Experi- 
mental Procedures. 
for the IFNa/@induced apoptosis of IL-7-dependent cells 
of B lineage. 
Type 1 IFN Receptors Are Expressed by Lymphoid 
Cell Lines of Diverse Phenotype 
The foregoing data indicate that cells that depend on IL-7 
for their growth are highly sensitive to lFNal6 treatment, 
whereas cell lines dependent on IL-2, IL-3, or IL-4 are not. 
To test for possible differences in expression of the lFNal8 
receptor (IFNal6R) by the different cell lines, we examined 
lFNal8R mRNA expression using the reverse transcript- 
ase-polymerase chain reaction (RT-PCR) method. In 
keeping with the demonstration that lFNal8 receptors are 
Figure 3. IFNa/b Effects on the Growth and Viability of an IL-7- 
Dependent Pro-B Cell Line Established from a bcl-2 Transgenic 
Mouse 
Cells were cultured and examined as in Figure 1. 
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expressed by virtually all tissues (Uze et al., 1990), all of 
the cell lines employed in these experiments were found 
to express lFNalf3R (data not shown). No obvious relation- 
ship was observed between the level of IFNalPR expres- 
sion (relative to 6-actin signal intensity) and sensitivity to 
IFNa@. For example, CTLL-2, whose growth was unaf- 
fected by IFNal8, expressed a relatively high level of IFNa/ 
f3R mRNA, whereas 2E8, which was very sensitive to 
IFNaQ, expressed less. These results suggest that the 
selective inhibition of IL-7 proliferation by IFNull cannot 
be attributed to variable IFNa@R expression. 
lFNa/P Inhibits IL-74ependent Growth of Normal B 
Cell Precursors 
Finding that IL-7-dependent cell lines are highly sensitive 
to growth inhibition by IFNa@, we wished to examine the 
sensitivity of the normal bone marrow cells that respond 
to IL-7. In a short-term assay in which nonadherent bone 
marrow cells were cultured in the presence of IL-7,lFNa/f3 
completely suppressed the IL-7-induced proliferation (Fig- 
ure 4A). Since bone marrow stromal cells that adhered to 
plastic were removed prior to this assay, it would appear 
that lFNal8 acts directlyon the IL-7 responsive lymphocyte 
precursors. In a long-term bone marrow culture system 
that favors the growth of B cell precursors (Whitlock and 
Witte, 1982) lFNal8 also effectively suppressed cellular 
proliferation (Figure 48). Although a variety of soluble fac- 
tors and direct contact by the stromal cells may be involved 
in thegeneration of B lymphocyte precursors in thisculture 
system, the IL-7-derived growth signal is an absolute re- 
quirement, since an antagonistic antibody directed 
against the IL-7R (A7R) completely abolished B lympho- 
poiesis (Figure 48). IL-7 is also a limiting factor for cell 
growth in this culture system, since adding exogenous 
recombinant IL-7 enhanced by several-fold the generation 
of B lineage cells (data not shown). Proliferation of B lin- 
eage cells from the bone marrow is thus highly dependent 
on the activity of IL-7 under both short- and long-term cul- 
ture conditions, and this IL-7-driven proliferation is highly 
sensitive to inhibition by type 1 IFNs. 
Both IFNa and IFNP Inhibit IL-74nduced Cell Growth 
The assays described above employed an IFNa@ mixture 
released by virus-infected cells. To confirm that the IFNal8 
proteins are responsible for the observed growth inhibition 
and to determine whether IFNa or lFN8 alone can exhibit 
inhibitory activity, specific neutralizing antibodies were 
added in the cell culture assays. Normal bone marrow cells 
(Figure 5A) and Scid7 cells (Figure 58) were employed in 
these experiments, For both types of cells, the combined 
addition of antibodies against IFNa and lFN6 resulted in 
virtually complete recovery of the IL-7-induced cell growth. 
Adding anti-IFNa antibody alone resulted in minimal re- 
coveryof cell growth, suggesting that the lFNf3 component 
of the lFNalf3 mixture is sufficient for growth inhibition. 
The addition of the anti-IFN6 antibody alone resulted in 
approximately 50% recovery in cell growth, implying that 
the IFNa component may also inhibit cell growth. In keep- 
ing with this interpretation, either purified IFNa or IFNf3 
IFNa@( U/ml) 
Weeks 
Figure 4. Interferon a/6 Inhibition of the IL-7-Dependent Proliferation 
of Bone Marrow Cells in Short-Term and Long-Term Culture Systems 
(A) Short-term culture system. Nonadherent bone marrow cells were 
cultured at lO?ml for 3 days with 100 U/ml of IL-7 and increasing 
concentrations of IFNa@. A control culture without IL-7 is included 
(-IL-7). 
(B) Long-term cultures of Whitlock-Whitte type were performed as 
described in Experimental Procedures. lFNal6 (1,000 U/ml) or A7R 
antibody (1 pglml) was added from the beginning of the cultures and 
replenished during weekly feedings of the cultures. Viable cell counts 
for the five culture dishes (6 cm) were performed weekly. Approxi- 
mately 70% of the nonadherent cells in the control cultures were found 
to express the 8220 B lineage marker at week 4. 
could inhibit cell growth (data not shown). The effective- 
ness of both IFNa and lFN6 in the inhibition of IL-7 re- 
sponses is concordant with the fact that both bind to the 
same cell surface receptor (Uze et al., 1990). 
IL-7R Expression Is Enhanced by IFNa/P Treatment 
lFNal6 down-regulation of the IL-7R on the IL-7-dependent 
cell lines could explain the growth inhibition, so this possi- 
bility was explored in experiments with the Scid7 and 
DW34 cell lines, both of which are IL-7 dependent. How- 
ever, IL-7R expression levels were not decreased by 
lFNalf3 treatment of either cell line. Instead, a slight in- 
crease in IL-7R expression was observed after IFNa@ 
treatment of both Scid7 (MFI of 124 versus 203 for IL-7R 
in control and IFNa@-treated cells, respectively) and of 
DW34 cells (MFI of 163 versus 219). Since a functional 
IRE is present in the promoter region of the murine IL-7R 
gene (Pleiman et al., 1991), the enhanced expression of 
IL-7R in these cells could be mediated by the IFNa/f3- 
induced transcriptional activator IRF-1 (Harada et al., 
1989). The data clearly mitigate against the possibility that 
lFNalf3 inhibits IL-7-dependent proliferation of early B lin- 
eage cells by down-regulating IL-7R expression. 
Bone Marrow Macrophages Produce Type 1 IFN 
Growth factors for early B lineage cells, such as IL-7, are 
secreted by bone marrow stromal cells, and stromal cell 
clones that secrete IL-7 can support the growth of early B 
cells. We confirmed the presence of IL-7 mRNA in resident 
bone marrow cells by RT-PCR analysis (data not shown). 
To determine whether type 1 IFNs might be produced by 
the bone marrow cells as potential physiological regulators 
of B lymphopoiesis, RT-PCR analysis was also used to 
search for IFN mRNA. The expression of lFN8 mRNA was 
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Figure 5. Neutralization of the Inhibitory Effects of lFNal5 by Anti-a 
and Anti-8 Antibodies 
(A) Fresh bone marrow cells (5 x IOVml) and (B) Scid7 cells (2 x 
1 04) were cultured in 96-well flat-bottomed plates and the [%]thymidine 
uptake was measured after 3 days. 
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Figure 6. lFN5 RNA Expression 
(A) Fresh bone marrow cells, adherent and nonadherent subpopula- 
tions of bone marrow cells, and adherent F4/80+ (a macrophage- 
specific surface antigen) and F4/80- cells. 
(B) Adherent and nonadherent bone marrow cells, long-term cultures 
(Whitlock-Witte type) of bone marrow cells and stromal cell lines. 
Fresh bone marrow cells from 3- to 8-week-old BALBlc mice were 
incubated in plastic flasks overnight to obtain the nonadherent and 
adherent subpopulations, the latter of which was further subdivided 
by immunofluorescence staining with the F4/80 macrophage-specific 
antibody and fluorescence-activated cell sorting. RNA was extracted 
from fresh bone marrow cells and constituent subpopulations and from 
bone marrow-derived stromal cell lines, and first-strand DNA synthe- 
sis and PCR amplification were performed as described in Experimen- 
tal Procedures. 
examined in these experiments, because there is only one 
murine lFNj3 gene versus approximately 12 IFNa genes 
(Hughes et al., 1994). lFN8 mRNA expression was indeed 
detectable in whole bone marrow preparations (Figure 
6A), leading us to examine whether bone marrow cells 
might secrete functionally active IFNal8. lFNal8 activity 
released by bone marrow cells in short-term cultures was 
assessed by the effect on Scid7 cell proliferation, In Scid7 
cell cultures containing the bone marrow supernatant, the 
addition of anti-IFNa and anti-IFN8 antibodies significantly 
enhanced cellular proliferation (Figure 7). Addition of the 
anti-IFN8 antibody alone enhanced cell growth, while anti- 
IFNa antibody by itself had no demonstrable effect. An 
isotype-matched control antibody also had no effect, and 
none of the antibodies enhanced the growth of Scid7 cells 
cultured in unconditioned media. These data suggest that, 
in addition to IL-7, the type 1 IFNs are constitutively pro- 
duced by bone marrow cells. 
To identify the responsible cell type in the bone marrow, 
four stromal cell lines that support the growth of B lineage 
cells (ST2, PA6, SlO, S17) were examined (see Figure 
6B). These stromal cell lines of bone marrow origin con- 
tained little or no IFN RNA that could be detected by RT- 
PCR. In addition, under conditions supporting the genera- 
tion of early B lineage cells, long-term cultures of adherent 
bone marrow cells expressed minimal levels of IFN RNA. 
When preparations of fresh bone marrow cells were sepa- 
rated into adherent and nonadherent populations, lFN8 
RNA was detectable primarily in the adherent cells (see 
Figure 6). When the adherent bone marrow cells were 
separated into F4/80 reactive and nonreactive subpopula- 
tions, the F4/80+ macrophages were found to be the major 
source of lFNf3 mRNA (see Figure 6A). 
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Figure 7. Evaluation of lFNal5 Activity in Bone Marrow Culture Super- 
natants 
Bone marrow cells isolated from 3-to lo-week-old BALBlc mice were 
cultured at 1OVml for 3 days before the supernatants were harvested 
and added to Scid7 cell culture to assay for lFNal8 activity. Two sepa- 
rate batches of culture supernatants were used in experiments 1 and 
2. Scid7 cells (10Vml in experiment 1 and 4 x 10Vml in experiment 
2) were cultured for 2 days in the bone marrow culture supernatant 
in thepresenceof IL-7(100U/ml)withorwithouttheadditionof antibod- 
ies to IFNa. IFN6, IFNalf3, or an isotype-matched control antibody. 
For analysis of the effects on PHjthymidine uptake as a measure of 
DNA synthesis, unpaired student’s t-test was calculated and the p 
values indicated (asterisk) were <O.Ol in experiment 1 and <0.05 in 
experiment 2. 
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Discussion 
The evidence presented here indicates that lFNal6 can 
act as selective antagonists of IL-7-induced cell growth of 
early B lineage cells. First, regardless of their precise 
stage in B lineage differentiation, IL-7-dependent cell lines 
are sensitive to IFNalf.? inhibition, while transformed IL-7- 
independent cell lines are not. Second, proliferation of 
the IL-7-responsive cells from normal bone marrow was 
inhibited by IFNa/6 in both short-term and long-term cul- 
ture assays, Third, for an IL-7nondependent pre-B cell 
line whose growth was enhanced by IL-7, lFNalf3 sup- 
presses the IL-7 component of the growth response, while 
leaving baseline growth unaffected. Fourth, lFNal6 treat- 
ment does not affect the proliferation of cell lines that are 
dependent on IL-2, IL-3, or IL-4. 
Novel Inhibitory Pattern of IFNa and IFNp 
A variety of factors may negatively regulate growth and 
differentiation of cells in the B lineage pathway. In a two- 
step culture system, in which lymphomyeloid progenitors 
are supported in the primary culture by a combination of 
SCF, erythropoietin, and IL-7 plus IL-6, IL-1 1, or GM-CSF, 
the pre-B cell potential of primary colonies can be abro- 
gated by IL-la and IL-3 (Hirayama et al., 1994). IL-la may 
induce the production of colony-stimulating factors that 
facilitate myelopoiesis whilesuppressing B lymphopoiesis 
(Dorshkind, 1988). IL-la and IL-3 thus may act to inhibit 
the commitment of multipotent progenitor cells to the B 
lineage. IL-la and IL-4 can inhibit the formation of pre-B 
cell colonies when added to secondary cultures that de- 
pend on the presence of IL-7 and SCF (Hirayama et al., 
1994). In addition, IL-1 a and IL4 can inhibit the differentia- 
tion of B220- progenitor cells into Cp+ pre-B cells (Billips 
et al., 1990). While these cytokines prevent the growth of 
committed pro-B cells and their differentiation into pre-B 
cells, neither IL-la nor IL-4 inhibit IL-7- and SCF-stim- 
ulated cell growth of established pre-B cell colonies(Hiray- 
ama et al., 1994). IFNy can inhibit the IL-7-driven growth 
of early B lineage cell clones that is also dependent on 
the presence of stromal cells (Grawunder et al., 1993; 
Garvy and Riley, 1994; Gimble et al., 1993). While IFNy 
thus may serve as an inhibitory factor for pro-B and pre-B 
cells, IL-7-dependent cell lines are not uniformly sensitive 
to IFNy (Gimble et al., 1993). Elevated estrogen levels can 
dramatically suppress B lymphopoiesis in vivo, probably 
via indirect effects on the bone marrow stromal cells (Me- 
dina et al., 1993; Medina and Kincade, 1994). In addition, 
the glucocorticoid hormone dexamethasone has recently 
been shown to induce apoptosis of pre-B and immature 
B cells (Merino et al., 1994). These observations infer that 
a variety of factors have the potential to check growth and 
development at different points in the B cell differentiation 
pathway. 
In contrast with the above inhibitory factors, our studies 
sugges! that IFNa/f3 can inhibit the IL-7-induced growth 
of IL-7-dependent cell lines regardless of their precise dif- 
ferentiationstatus. Scid7and DIFS(surface w- pro-B lines), 
57.10, lXNRB, and DW34 (surface p+ pre-B lines), and 
2E8 (surface P+K+‘- transitional pre-BIB cells) were all sen- 
sitive to IFNalp-induced growth arrest. Conversely, growth 
of the 2E8 cells could not be inhibited by IFNy (Gimble et 
al., 1993). lFNal6 and IFNy use different receptors and 
distinct signal transduction pathways (Pellegrini and 
Schindler, 1993), and thus may haveoverlapping, but non- 
identical, growth inhibitory effects. 
IFNa and IFNp Induce Programmed Cell Death 
in Early B Lineage Cells 
IL-7 can serve both to relieve programmed cell death by 
early B lineage clones and to promote their proliferation 
at the expense of undergoing B cell differentiation (Rolink 
et al., 1991b). In our studies, the type 1 IFNs, a and 6, 
were shown to negate effectively the IL-7 response of early 
B lineage cells and to reinstitute the program for apoptotic 
cell death. 
While IFNa/f3 inhibited the IL-7-dependent proliferation 
of normal bone marrow cells and B lineage cell lines, vari- 
ability in the apoptotic response pattern was noted for dif- 
ferent IL-7-dependent cell lines. For the u+ pre-B cell lines 
and the transitional pre-BIB cell line (2E8), the percentage 
of apoptotic cells induced by lFNal6 was no more than 
half that observed following IL-7 deprivation. By contrast, 
in experiments employing the pro-B cell lines Scid7 and 
DIF9, IFNa/6 induced a percentage of apoptotic cells simi- 
lar to that caused by factor withdrawal. These observations 
suggest that p chain-negative cell lines may be more sen- 
sitive to IFNa/f%induced apoptosis than are u chain-posi- 
tive cells. A possible exception to this rule is the p+ pre-B 
cell line DW34 that appears to be more sensitive to IFNa/6 
than to IL-7 deprivation. However, this cell line secretes 
IL-7 in low levels and can grow in an autocrine fashion 
when cultured at sufficiently high cell density (unpublished 
data). The lower percentage of apoptotic cells following 
IL-7 deprivation in this case may thus reflect this autocrine 
effect. 
Hemopoietic cell growth factors may function to main- 
tain cell viability both by suppressing apoptosis and by 
stimulating proliferation (Fairbairn et al., 1993). While both 
responses can occur as a consequence of the same 
growth factor-receptor interaction, the actual response 
pattern may be differentially governed by the level of re- 
ceptor occupancy. Thus, at low growth factor concentra- 
tions, the cells may survive without dividing (Stanley and 
Guilbert, 1981; Tushinski et al., 1982). Our data suggest 
that while the IL-7-derived growth signals are consistently 
abolished by IFNalf3, IL-7-derived survival signals are not 
necessarily inhibited in parallel fashion. For the IXNBB, 
5.7.10, and 2E8 cell lines (Table l), the percentage of 
apoptotic cells induced by IFNa/6 was one-half or less 
than that induced by growth factor deprivation. lFNal6 
therefore may inhibit most, but not all, IL-7-derived signals. 
Whereas bcl-2 was found to be expressed at similar levels 
by the IL-7-dependent pre-B cell line, Scid7, and the IL-3- 
dependent cell line, FDC-1, bcl-2 expression was down- 
regulated by IFNaI6 only in the Scid7 cells, suggesting 
the possibility that bcl-2 down-regulation may contribute 
to the induction of apoptosis by lFNal8 in the presence 
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of IL-7. In support of this possibility, an IL-7-dependent 
pro-6 cell line derived from a bcl-2 transgenic mouse was 
relatively resistant to IFNa@-induced cell death while re- 
taining its sensitivity to growth inhibition by IFNalj3. 
Type 1 IFNs can induce the expression of two transcrip- 
tion factors, IRF-1, a transcriptional activator, and IRF-2, 
a transcriptional repressor. Exposure of cells to type 1 
IFNs initially induces IRF-1 and later the production of 
IRF-2 (Harada et al., 1989). Interestingly, B cell develop- 
ment is effectively aborted at a relatively early stage by 
up-regulated IRF-1 expression. This was shown in trans- 
genie mice carrying an IRF-1 cDNA under the control of 
immunoglobulin heavy chain promoter and enhancer (Ya- 
mada et al., 1991). These mice have limited numbers of 
822O’lymphocytes in the bone marrow and they lack IgM’ 
B cells in their peripheral lymphoid tissue. IL-7-responsive 
cells are undetectable in the bone marrow of the IRF-1 
transgenic mice (Yamada et al., 1991). IRF-1 overexpres- 
sion thus aborts B cell development at the stage at which 
cells in this lineage become responsive to IL-7. Coupled 
with the fact that lFNalj3 induces IRF-1 expression, these 
data suggest that the growth inhibitory effects of IFNal 
j3 on IL-7-dependent cells is the consequence of IRF-1 
induction. 
Since the IL-2, IL-4 and IL-7 receptors all share the signal 
transducing y chain in common (Kondo et al., 1993; No- 
guchi et al., 1993; Russell et al., 1993) it is remarkable 
that lFNalj3 inhibits the growth signal induced by IL-7, and 
not those induced by IL-2, IL-3, or IL-4. If IRF-1 induction 
is indeed critical for the inhibitory effect on IL-7-dependent 
cell lines, it is possible that lFNalj3 does not activate a 
signal transduction pathway leading to IRF-1 expression 
in the cell lines that are growth dependent on IL-2, IL-3, 
or IL-4. Alternatively, IFNal8 may not induce other signals, 
which are needed to counteract IL-2, IL-3, or IL-4 growth 
signals and to induce apoptosis. Since the IL-2-, IL-3-, and 
IL-4-dependent cells all express IFNa@R, it appears un- 
likely that lFNalf3 receptor-mediated signals can interfere 
with thegrowth signals initiated bythese cytokines. lFNalf3 
receptor-mediated activation of IRF-1 and ISGF-3 (Fu et 
al., 1990) is currently being investigated in the different 
cell lines. 
Resident Bone Marrow Cells Produce Type 1 IFN 
While lFNalj3 of exogeneous origin effectively inhibited 
the IL-7-dependent growth of normal bone marrow precur- 
sors, evidence for IFN production by cells native to the 
bone marrow would be required to imply physiological rele- 
vance of this finding. IFNalf3 activity could indeed be dem- 
onstrated in supernatants from whole bone marrow cul- 
tures, and lFNf3 RNA was detected in fresh bone marrow 
cells. When bone marrow subpopulations were isolated 
and their potential for lFN8 synthesis examined, the resi- 
dent population of bone marrow macrophages proved to 
be the principle source of lFNf3 RNA. Stromal cell lines 
possessed little or no lFN8 RNA. Interestingly, relatively 
limited levels of IFNP RNA appeared to be expressed in 
long-term bone marrow cultures of early B lineage cells, 
although these cultures contain many macrophages. 
Conclusions and Speculation 
The exquisite sensitivity of early B lineage cells to IFNal 
P-induced apoptosis raises the possibility that lFNalj3 
could be involved in eliminating incompetent progenitor 
cells. Selective cell death at the late pro-B cell stage is 
indicated by the kinetic analysis of lymphocyte subpopula- 
tions in the bone marrow (Osmond et al., 1994) and the 
selective loss of cells with nonproductive VDJ rearrange- 
ment has been documented during the progression of B 
lineage differentiation in the bone marrow (Rajewsky, 
1992). Scid mice, severely impaired in their ability to as- 
semble functional immunoglobulin genes (see Bosma and 
Carroll, 1991) and mice bearing deletions in their Jk, RAG, 
urn or h5 genes, thereby rendering them incapable of ex- 
pressing immunoglobulin receptors (Ehlich et al., 1993, 
1994; Shinkai et al., 1993) all have limited numbers of 
cells beyond the late pro-B cell stage (between fractions 
C and C’ in the Hardy scheme) in the B lineage pathway 
(Desiderio, 1994). Paradoxically, Scid pre-B cells exhibit 
an essentially normal growth pattern in long-term cultures 
under conditions in which bone marrow stromal cells pro- 
vide the growth support (Witte et al., 1987) and where 
limited lFNf3 expression could be demonstrated. The 
mechanism by which bone marrow precursors lacking a 
functional u chain receptor are eliminated in an in vivo 
environment containing IL-7 could therefore reflect the dif- 
ferential sensitivity of these cells to IFNa@-induced apop- 
tosis, a hypothetical possibility suggested by our analysis 
of a limited number of representative cell lines. The bone 
marrow macrophages appear to serve as the graveyard 
for B lineage cells undergoing apoptosis (Osmond et al., 
1994) and our data implicate the macrophage a8 a source 
for lFN8 that potentially could trigger the deletion of dys- 
functional B lineage cells. Additional experiments will be 
required to test the validity of this hypothesis. 
In conclusion, the current data suggest that IFNa and 
lFNj3 can interfere with IL-7-derived growth signals to 
reinstitute programmed cell death of early B lineage cells. 
Analysis of a limited number of IL-7-dependent lines sug- 
gests that pro-B cells may be more sensitive than pre-B 
cell lines to IFNa/8-induced apoptosis. The constitutive 
expression of IL-7 and type 1 IFNs by separate populations 
of resident bone marrow cells suggests that these factors 
may be differentially involved in the regulation of B lineage 
progenitors. The elucidation of a physiological inhibitory 
pathway that specifically counters IL-7induced prolifera- 
tion could lead to improved understanding of the selective 
survival of immunocompetent B lineage cells. 
Experimental Procedures 
Cytokines and Antibodies 
IL-7 was produced by transfecting a murine IL-7 expression vector 
(provided by Dr. L. Park, Immunex, Seatle. Washington) into COS 
cells. COS cell supernatant was collected 5 days after transfection 
and the IL-7 activity was determined in an IL-7-dependent cell line, 
Scid7, using recombinant IL-7(Genzyme, Boston, Massachusetts)asa 
standard. The IL-3-containing supernatant of WEHIS cells was similarly 
titrated using FDC-1, an IL-3dependent cell line. Recombinant IL-2 
and IL-4 were provided by Dr. H. Kiyono (University of Alabama at 
Birmingham). lFNal5 was purchased from Sigma Chemical Company 
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(St. Louis, Missouri) and contained a mixture of natural IFNa and p 
secreted by mouse L cells after challenge with the Newcastle Disease 
Virus. Purified IFNa and p were purchased from ICNIFLOW. Neutraliz- 
ing antibodies against mouse IFNa or IFNB were purchased from Sei- 
kagaku Kougyo (Japan). The IL-7 receptor antibody, A7R, was pro- 
vided by Dr. S-i. Nishikawa (Kyoto University, Japan). Fluorescein 
isothiocyanate-conjugated anti-bcl-2 antibody was purchased from 
DAK0 (Denmark). The F4/80 monoclonal antibody was obtained from 
Caltag Laboratories (San Francisco, California). 
Cell Llnes and Cell Culture 
The IL-7-dependent cell lines, Scid7, DW34, and the bcl-2-pro-8 cell 
line derived from an Eflbcl-2 transgenic mouse were provided by Dr. 
S.-i. Nishikawa (Kyoto University, Japan), lXN/PB by Dr. A. Namen 
(Immunex),5.7.10 byDr.A. Rolink(Basel Institutefor Immunology)and 
DIFSandSEB byDr. J. Kearney(UniversityofAlabamaat Birmingham). 
The IL-2-dependentcell lines(HT2ABand CTLL-2), the IL-3-dependent 
cell line (FDC-I), and the IL-Cdependent cell line (CT4S) were obtained 
from Drs. K. Honjo and J. Kearney (University of Alabama at Bir- 
mingham). Cells were cultured in RPM 1640 (GIBCO BRL) containing 
5 x 10m5 M 2-mercaptoethanol, 100 U/ml penicillin and streptomycin, 
supplemented with 10% fetal calf serum (Hyclone). Cyiokines (IL-2, 
IL-3, IL-4, or IL-7, 100 U/ml) were used to maintain the cytokine- 
dependent cell lines. 
Proliferation Assays 
In most cases, cells (200 PI at a concentration of 1 x lo4 cells/ml) 
were cultured in 96-well flat-bottomed plates for 2-3 days. Cultures 
were pulsed for the last 8 hr with 1 pCi = 37 kBq [3H]thymidine and 
harvested onto glass fiber filters. The incorporated radioactivity was 
determined in a liquid scintillation counter. Mean 13H]thymidine incor- 
poration and standard deviation were determined for quadruplicate 
cultures. 
Bone Marrow Cultures 
Bone marrow cellsobtained from 3-to lo-week-old BALBlc mice were 
depleted of adherent cells by filtration over a Sephadex GlO column 
as described (Billips et al., 1992). Long-term bone marrow cultures 
were performed using 3-week-old mice as described (Whitlock and 
Witte, 1982). Each week of the culture interval, two-thirds of the media 
was removed and replaced with fresh media with or without added 
IFNalP (1 ,OO U/ml) or anti-IL-7 receptor antibody (A7R, 1 vg/ml). 
Cell Viability and Cell Cycle Analysis 
Cells were stained with 1 pg/ml propidium iodide (PI) in phosphate- 
buffered saline (PBS) containing 2% fetal calf serum and 0.02% NaN, 
for 5 min on ice and the percentages of PI-positive (dead) and PI- 
negative (live) cells were analyzed with a FACScan flow cytometer 
(Becton Dickinson and Company, Mountain View, California). For cell 
cycle analysis, lo6 cells were fixed on ice in 1 ml of 70% cold ethanol 
for 30 min, followed by staining in PBS containing 0.25 mg/ml RNase 
A and 50 bg/ml PI at 37OC for 30 min. Cell cycle analysiswas performed 
with a FACScan flow cytometer. 
Extraction of DNA 
Approximately lo6 cells were placed on ice for 10 min in 100 ~1 of 
lysis buffer containing 10 mM Tris (pH 7.5). 1OmM EDTA. and 0.2% 
Triton X-l 00, then the cell lysates were centrifuged for 10 min at 15,000 
rpm at 4OC. The supernatant was transferred to a new tube and the 
DNA precipitated in 1110 volume of 3 M sodium acetate (pH 5.2) and 
2 vol of cold ethanol. The precipitated DNA was resuspended in 20 
~1 of TE (10 mM Tris, 1 mM EDTA [pH 8.01) containing 10 pg/ml of 
RNase A and incubated at 37OC for 15 min before loading onto a 1.5% 
agarose gel. 
lmmunofluorescence Analysis 
To evaluate IL-7R expression, cells (approximately 106) were stained 
with biotinated A7R antibody on ice for 15 min, washed twice with 
staining medium (PBS containing 2% fetal calf serum and 0.02% so- 
dium azide), and incubated with streptavidin-conjugated phycoerythrin 
(SPPQCellsstainedonlywith SAPEservedascontrols. Bcl-2staining 
was performed following the protocol provided by the manufacturer 
(DAKO). In brief, cells (103 were fixed with 0.25% paraformaldehyde 
for 15 min at room temperature, washed with PBS. and incubated with 
70% cold ethanol on ice for 1 hr. After washing, the cells were first 
blocked with an isotype-matched control antibody, washed again, and 
stained either with fluorescein isothiocyanate-conjugated anti-Bcl-2 
or a control antibody. 
IFNaQ Receptor and lFNf3 mRNA Analysis 
For these assays involving reverse transcription and amplification by 
the RT-PCR, total RNA was extracted from approximately lo6 cells 
by an acid guanidium thiocyanate-phenol-chloroform method (Chom- 
czynski and Sacchi, 1987). First-strand cDNA was synthesized using 
AMV reverse transcriptase and oligo dT as a primer in a 20 pl reaction. 
PCR was performed for 35 cycles in 50 pl buffer containing 200 IM 
each dNTP. 25 pmol each primer, and 2.5 U Taq polymerase (GIBCO), 
and 5 ~1 of the first-strand cDNA. For IFNa/PR gene expression, for- 
ward (5’-ACAGCACATGTGATGGACT-3’) and reverse (5’-TGTGAGC- 
TGTACTTCCTGA-3) primers were used under the following condi- 
tions: 94OC for 1 min; 56OC for 1.5 min; 72OC for 2 min. The PCR 
products were separated in 1.5% agarose gels, transferred to nylon 
membranes, and hybridized with a “P-labeled internal primer (5’- 
CTGTCATGGTCCTITATGC). For B-actin gene expression, the for- 
ward (5”TAGACTTCGAGCAGGAGGAGATG-3’) and reverse (5’~CGT- 
ACTCCTGCTTGCTGATCCA-3’) primers were used for amplification 
at 94O for 1 min, 65O for 1.5 min, and 72’C for 2 min. Similarly, the 
p-actin PCR productswere hybridized with a “P-labeled internal primer 
(5’-TCCATCATGAAGTGTGACGT-31. For IFNB gene expression by 
bone marrow cells and stromal cell lines (SlO, 517, PA6, and ST2). 
total RNA was extracted using RNAzolTMB (Biotecx Laboratories, In- 
corporated). Since the IFNB gene does not contain an intron in the 
coding region, contaminating genomic DNA would yield the same PCR 
product as that from cDNA. For this reason, RNA isolated from bone 
marrow cells was first treated with RNase-free DNase I at 37OC for 1 
hr to digest any contaminating DNA, and this was followed by two 
rounds of phenollchloroformlisoamyl alcohol extraction before synthe- 
sizing the first-strand DNA. Theforwardand reverse IFNBgeneprimers 
were5’-CCTGGAGCAGCTGAATGGAA-3’and5’-GTACCTTTGCACC- 
CTCCAGT-3’. The PCR was performed at 94°C for 1 min, 62OC for 
1.5 min, and 72’C for 2 min. An internal primer (5’-AGCACTGGG- 
TGGAATGAGAC-3) was used to detect the PCR product. As a control 
for these PCR, PCR products were amplified from a first-strand cDNA 
reaction from which reverse transcriptase was omitted. 
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